What were the results of the Heart Outcomes Prevention Evaluation (HOPE) study?
The Heart Outcomes Prevention Evaluation (HOPE) study was a randomized controlled trial (RCT) involving patients with diabetes or vascular disease and at least one other CVD risk factor. The results showed that ramipril prevented progression of proteinuria or development of new-onset microalbuminuria, independent of other factors.